Hemo Organic Ltd
₹ 12.2
4.83%
26 Apr
- close price
About
Incorporated in 1992, Hemo Organic Ltd manufactures Ayurvedik or Unani pharmaceutical preparation[1]
Key Points
- Market Cap ₹ 4.22 Cr.
- Current Price ₹ 12.2
- High / Low ₹ 12.4 / 5.57
- Stock P/E
- Book Value ₹ -0.23
- Dividend Yield 0.00 %
- ROCE -250 %
- ROE %
- Face Value ₹ 10.0
Pros
Cons
- Company has low interest coverage ratio.
- Promoter holding is low: 16.8%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
0.81 | 0.57 | 0.71 | 0.16 | 0.11 | 0.60 | 0.09 | 0.05 | 0.27 | 0.01 | 0.01 | -0.00 | 0.00 | |
1.23 | 0.49 | 0.79 | 0.22 | 0.16 | 0.68 | 0.24 | 0.17 | 0.29 | 0.06 | 0.07 | 0.05 | 0.08 | |
Operating Profit | -0.42 | 0.08 | -0.08 | -0.06 | -0.05 | -0.08 | -0.15 | -0.12 | -0.02 | -0.05 | -0.06 | -0.05 | -0.08 |
OPM % | -51.85% | 14.04% | -11.27% | -37.50% | -45.45% | -13.33% | -166.67% | -240.00% | -7.41% | -500.00% | -600.00% | ||
0.06 | -0.72 | 0.23 | 0.02 | -0.71 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | 0.00 | |
Interest | 0.04 | 0.03 | 0.02 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | 0.00 |
Depreciation | 0.10 | 0.09 | 0.09 | 0.07 | 0.06 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | 0.00 |
Profit before tax | -0.50 | -0.76 | 0.04 | -0.11 | -0.82 | -0.08 | -0.15 | -0.12 | -0.02 | -0.05 | -0.06 | -0.05 | -0.08 |
Tax % | 26.00% | 1.32% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | |
-0.37 | -0.76 | 0.04 | -0.11 | -0.82 | -0.08 | -0.15 | -0.12 | -0.02 | -0.05 | -0.06 | -0.05 | -0.08 | |
EPS in Rs | -1.07 | -2.19 | 0.12 | -0.32 | -2.37 | -0.23 | -0.43 | -0.35 | -0.06 | -0.14 | -0.17 | -0.14 | -0.23 |
Dividend Payout % | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | -100% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 11% |
3 Years: | % |
TTM: | -700% |
Stock Price CAGR | |
---|---|
10 Years: | 3% |
5 Years: | -6% |
3 Years: | -6% |
1 Year: | 43% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
Last Year: | % |
Balance Sheet
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 3.40 | 3.40 | 3.40 | 3.40 | 3.40 | 3.47 | 3.47 | 3.47 | 3.47 | 3.47 | 3.47 | 3.47 | 3.47 |
Reserves | -1.20 | -1.96 | -1.92 | -2.16 | -2.98 | -3.06 | -3.21 | -3.33 | -3.35 | -3.40 | -3.46 | -3.52 | -3.55 |
0.27 | 0.25 | 0.05 | 0.05 | -0.00 | -0.00 | 0.08 | 0.08 | -0.00 | 0.04 | 0.04 | 0.04 | 0.04 | |
0.05 | 0.07 | 0.14 | 0.08 | 0.11 | 0.72 | 0.66 | 0.73 | 0.13 | 0.12 | 0.19 | 0.35 | 0.34 | |
Total Liabilities | 2.52 | 1.76 | 1.67 | 1.37 | 0.53 | 1.13 | 1.00 | 0.95 | 0.25 | 0.23 | 0.24 | 0.34 | 0.30 |
1.33 | 1.23 | 1.12 | 0.92 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | |
CWIP | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
Investments | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
1.19 | 0.53 | 0.55 | 0.45 | 0.53 | 1.13 | 1.00 | 0.95 | 0.25 | 0.23 | 0.24 | 0.34 | 0.30 | |
Total Assets | 2.52 | 1.76 | 1.67 | 1.37 | 0.53 | 1.13 | 1.00 | 0.95 | 0.25 | 0.23 | 0.24 | 0.34 | 0.30 |
Cash Flows
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
-0.16 | -0.36 | 0.06 | 0.06 | -0.78 | -0.15 | -0.12 | -0.04 | 0.01 | -0.01 | -0.00 | 0.11 | |
0.36 | 0.41 | 0.02 | -0.00 | 0.70 | 0.02 | 0.06 | 0.04 | -0.00 | -0.00 | -0.00 | -0.00 | |
-0.16 | -0.05 | -0.17 | -0.00 | 0.08 | 0.15 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | |
Net Cash Flow | 0.04 | -0.00 | -0.09 | 0.07 | -0.00 | 0.01 | -0.06 | -0.01 | 0.01 | -0.01 | -0.00 | 0.11 |
Ratios
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 135.19 | 134.47 | 159.37 | 342.19 | -0.00 | 438.00 | 2,920.00 | 5,402.00 | 94.63 | 2,555.00 | 2,190.00 | |
Inventory Days | 33.95 | -0.00 | -0.00 | -0.00 | -0.00 | 20.66 | 91.25 | -0.00 | -0.00 | -0.00 | 730.00 | |
Days Payable | 8.49 | 392.55 | 3,011.25 | 4,015.00 | ||||||||
Cash Conversion Cycle | 160.65 | 134.47 | 159.37 | 342.19 | -0.00 | 66.11 | -0.00 | 5,402.00 | 94.63 | 2,555.00 | -1,095.00 | |
Working Capital Days | 117.16 | 70.44 | 97.68 | 228.12 | 232.27 | 146.00 | 689.44 | 438.00 | -67.59 | -1,825.00 | -4,015.00 | |
ROCE % | -16.97% | 0.96% | -10.56% | -7.80% | -12.87% | -19.28% | -40.00% | -42.86% | -11.76% | -43.48% | -75.00% | -250.00% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Change in Management
18 Apr - The Board of the company, in their meeting held on today, ie. April 18, 2024, at the registered office of the company which was commenced …
- Board Meeting Outcome for Appointment Of Mr. Anand Lavingia, Practicing Company Secretary As Secretarial Auditor For Obtaining Secretarial Audit Report For Financial Year 2023-24. 18 Apr
- Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2 17 Apr
- Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 17 Apr
- Submission Of Compliance Certificate In Pursuance Of Regulation 7(3) Of SEBI (LODR) Regulations, 2015 For The Financial Year Ended On March 31, 2024 16 Apr
Annual reports
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
-
Financial Year 2009
from bse
Product Profile:[1][2]
Company used to manufacture 2,6 Di Chloro Aniline which is used as an intermediate in bulk drugs and Para Chloro Meta Cresol which is used in the leather industry in its Kheda plant with an installed capacity of 110 MTPA for 2,6 Dichloro aniline and 220 MTPA for para Chloro Meta Cresol. At present, company deals in ayurvedic or unani preparations